News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
258,677 Results
Type
Article (17584)
Company Profile (69)
Press Release (241024)
Multimedia
Podcasts (9)
Webinars (5)
Section
Business (78714)
Career Advice (570)
Deals (21673)
Drug Delivery (30)
Drug Development (23447)
Employer Resources (39)
FDA (6484)
Job Trends (6837)
News (133618)
Policy (13201)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (3)
2024 Bio NC Digital (3)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
Academia (1174)
Academic (1)
Accelerated approval (1)
Adcomms (2)
Allergies (29)
Alliances (24782)
ALS (26)
Alzheimer's disease (437)
Antibody-drug conjugate (ADC) (67)
Approvals (6543)
Artificial intelligence (149)
Autoimmune disease (10)
Automation (10)
Bankruptcy (130)
Best Places to Work (5446)
BIOSECURE Act (4)
Biosimilars (18)
Biotechnology (50)
Bladder cancer (22)
Brain cancer (15)
Breast cancer (111)
Cancer (846)
Cardiovascular disease (66)
Career advice (505)
Career pathing (7)
CAR-T (50)
Cell therapy (146)
Cervical cancer (12)
Clinical research (18921)
Collaboration (490)
Compensation (39)
Complete response letters (7)
COVID-19 (1029)
CRISPR (13)
C-suite (70)
Cystic fibrosis (30)
Data (765)
Depression (15)
Diabetes (84)
Diagnostics (4056)
Digital health (11)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (65)
Drug pricing (19)
Drug shortages (6)
Duchenne muscular dystrophy (23)
Earnings (28613)
Editorial (8)
Employer branding (5)
Employer resources (35)
Events (25054)
Executive appointments (260)
FDA (6976)
Featured Employer (9)
Friedreich's ataxia (2)
Frontotemporal dementia (2)
Funding (275)
Gene editing (35)
Generative AI (14)
Gene therapy (105)
GLP-1 (348)
Government (2081)
Grass and pollen (3)
Guidances (29)
Healthcare (6655)
Huntington's disease (2)
IgA nephropathy (10)
Immunology and inflammation (39)
Indications (8)
Infectious disease (1085)
Inflammatory bowel disease (49)
Inflation Reduction Act (3)
Influenza (25)
Intellectual property (52)
Interviews (82)
IPO (6091)
IRA (9)
Job creations (1643)
Job search strategy (434)
Kidney cancer (1)
Labor market (5)
Layoffs (164)
Leadership (3)
Legal (3039)
Liver cancer (24)
Lung cancer (133)
Lymphoma (59)
Machine learning (2)
Management (10)
Manufacturing (137)
MASH (18)
Medical device (5010)
Medtech (5011)
Mergers & acquisitions (15984)
Metabolic disorders (227)
Multiple sclerosis (33)
NASH (7)
Neurodegenerative disease (35)
Neuropsychiatric disorders (10)
Neuroscience (632)
NextGen: Class of 2025 (2454)
Non-profit (1421)
Northern California (783)
Now hiring (12)
Obesity (124)
Opinion (90)
Ovarian cancer (17)
Pain (22)
Pancreatic cancer (22)
Parkinson's disease (45)
Partnered (11)
Patents (80)
Patient recruitment (24)
Peanut (15)
People (20404)
Pharmaceutical (19)
Pharmacy benefit managers (3)
Phase I (5353)
Phase II (7833)
Phase III (7233)
Pipeline (523)
Policy (28)
Postmarket research (874)
Preclinical (2524)
Press Release (23)
Prostate cancer (41)
Psychedelics (6)
Radiopharmaceuticals (100)
Rare diseases (128)
Real estate (2921)
Recruiting (13)
Regulatory (8924)
Reports (20)
Research institute (1117)
Resumes & cover letters (89)
Rett syndrome (4)
RSV (12)
Schizophrenia (32)
Series A (59)
Series B (31)
Service/supplier (2)
Sickle cell disease (17)
Southern California (696)
Special edition (5)
Spinal muscular atrophy (75)
Sponsored (16)
Startups (1550)
State (1)
Stomach cancer (4)
Supply chain (26)
Tariffs (4)
The Weekly (9)
United States (7650)
Vaccines (208)
Venture capitalists (12)
Weight loss (92)
Women's health (6)
Worklife (2)
Date
Last 7 days (169)
Last 30 days (811)
Last 365 days (12704)
2025 (3790)
2024 (13177)
2023 (14840)
2022 (21185)
2021 (22377)
2020 (21949)
2019 (17627)
2018 (13838)
2017 (13176)
2016 (12463)
2015 (14432)
2014 (10791)
2013 (9091)
2012 (9584)
2011 (10171)
2010 (9077)
Location
Africa (298)
Alabama (16)
Alaska (2)
Arizona (74)
Arkansas (6)
Asia (16355)
Australia (2512)
California (1852)
Canada (723)
China (176)
Colorado (83)
Connecticut (95)
Delaware (54)
Europe (37418)
Florida (343)
Georgia (65)
Idaho (20)
Illinois (163)
India (7)
Indiana (127)
Iowa (3)
Japan (77)
Kansas (37)
Kentucky (10)
Louisiana (6)
Maine (28)
Maryland (407)
Massachusetts (1310)
Michigan (111)
Minnesota (83)
Mississippi (1)
Missouri (45)
Montana (11)
Nebraska (5)
Nevada (12)
New Hampshire (24)
New Jersey (698)
New Mexico (11)
New York (542)
North Carolina (403)
North Dakota (3)
Northern California (783)
Ohio (85)
Oklahoma (4)
Oregon (6)
Pennsylvania (437)
Puerto Rico (4)
Rhode Island (14)
South America (452)
South Carolina (9)
Southern California (696)
Tennessee (63)
Texas (292)
Utah (73)
Virginia (46)
Washington D.C. (21)
Washington State (169)
West Virginia (2)
Wisconsin (26)
258,677 Results for "adac laboratories acquired by royal philips electronics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Philips completes cancellation of 4.4 million shares
Royal Philips announced that it has completed the cancellation of 4,437,164 of its shares.
June 19, 2024
·
1 min read
Press Releases
Philips publishes its Annual Report 2024
February 24, 2025
·
2 min read
Business
Philips shareholders approve all proposals at the AGM 2024
Royal Philips, announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders 2024, including:
May 7, 2024
·
4 min read
Philips announces exchange ratio for 2023 dividend
Royal Philips, announced that the exchange ratio for the dividend for the year 2023 is 1 new common share for every 29.2684 existing common shares.
May 15, 2024
·
2 min read
Business
Philips publishes its Annual Report 2023
Royal Philips, a global leader in health technology, published its Annual Report 2023.
February 20, 2024
·
2 min read
Press Releases
Philips demonstrates innovation power, topping European Patent Office Medtech filings in 2024
March 25, 2025
·
3 min read
Philips convenes the Annual General Meeting of Shareholders 2024
Royal Philips, announced it has convened the Annual General Meeting of Shareholders 2024 and published the agenda with explanatory notes.
March 22, 2024
·
2 min read
Genetown
Philips presents study results at Heart Rhythm Annual Meeting demonstrating benefits of its AI-powered cardiac monitoring solutions
Royal Philips a global leader in health technology, is presenting new retrospective study results demonstrating the clinical and economic benefits of Philips’ AI-powered cardiac care solutions at the Heart Rhythm Annual Meeting in Boston.
May 17, 2024
·
6 min read
Philips delivers strong ESG performance in 2023
Royal Philips, a global leader in health technology, has relentlessly focused on further improving its Environmental, Social, and Governance performance in 2023.
February 20, 2024
·
6 min read
Press Releases
Xcell Biosciences and Royal Perth Hospital to Develop Next Gen Automated TIL Manufacturing Workflow
March 19, 2025
·
3 min read
1 of 25,868
Next
